Bank of New York Mellon Corp Decreases Position in ICU Medical, Inc. (ICUI)

Bank of New York Mellon Corp trimmed its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 2.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 185,148 shares of the medical instruments supplier’s stock after selling 3,999 shares during the period. Bank of New York Mellon Corp owned 0.94% of ICU Medical worth $31,938,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in the stock. Alps Advisors Inc. boosted its position in ICU Medical by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 3,130 shares of the medical instruments supplier’s stock worth $540,000 after purchasing an additional 8 shares during the period. SG Americas Securities LLC boosted its position in ICU Medical by 215.1% during the 2nd quarter. SG Americas Securities LLC now owns 2,373 shares of the medical instruments supplier’s stock worth $409,000 after purchasing an additional 1,620 shares during the period. LLBH Private Wealth Management LLC purchased a new stake in ICU Medical during the 2nd quarter worth $321,000. Teacher Retirement System of Texas purchased a new stake in ICU Medical during the 2nd quarter worth $214,000. Finally, Arizona State Retirement System boosted its position in ICU Medical by 1.3% during the 2nd quarter. Arizona State Retirement System now owns 7,874 shares of the medical instruments supplier’s stock worth $1,358,000 after purchasing an additional 100 shares during the period. 78.13% of the stock is owned by hedge funds and other institutional investors.

A number of brokerages recently weighed in on ICUI. BidaskClub cut shares of ICU Medical from a “hold” rating to a “sell” rating in a research report on Thursday, August 24th. Zacks Investment Research cut shares of ICU Medical from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 15th. Gabelli reaffirmed a “buy” rating on shares of ICU Medical in a research report on Friday, August 11th. Finally, Sidoti cut shares of ICU Medical from a “buy” rating to a “neutral” rating in a research report on Tuesday, June 20th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $193.00.

ICU Medical, Inc. (ICUI) opened at 177.35 on Monday. The firm has a 50-day moving average of $171.40 and a 200-day moving average of $162.77. ICU Medical, Inc. has a one year low of $120.14 and a one year high of $178.20. The firm has a market cap of $3.52 billion, a price-to-earnings ratio of 71.03 and a beta of 0.36.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by $0.06. ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The business had revenue of $331.51 million for the quarter, compared to analyst estimates of $318.30 million. During the same quarter last year, the company earned $1.15 EPS. The business’s revenue for the quarter was up 242.8% compared to the same quarter last year. Analysts anticipate that ICU Medical, Inc. will post $4.11 EPS for the current year.

In other news, CEO Vivek Jain sold 69,014 shares of the stock in a transaction on Friday, July 7th. The shares were sold at an average price of $171.10, for a total transaction of $11,808,295.40. Following the transaction, the chief executive officer now owns 110,925 shares in the company, valued at approximately $18,979,267.50. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Scott E. Lamb sold 23,772 shares of the stock in a transaction on Tuesday, July 11th. The stock was sold at an average price of $170.02, for a total transaction of $4,041,715.44. Following the transaction, the chief financial officer now owns 9,050 shares in the company, valued at approximately $1,538,681. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 212,549 shares of company stock worth $36,354,740. 15.90% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION WARNING: “Bank of New York Mellon Corp Decreases Position in ICU Medical, Inc. (ICUI)” was first posted by Markets Daily and is owned by of Markets Daily. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.themarketsdaily.com/2017/09/11/bank-of-new-york-mellon-corp-decreases-position-in-icu-medical-inc-icui.html.

ICU Medical Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply